
Empowering Prostate Cancer Patients: Combating Misinformation and Optimizing Lifestyle
There are many evidence-based recommendations for nutrition and lifestyle in prostate cancer. Failure to counsel patients on nutrition and lifestyle leads to lower quality of care. It is important that the radiation oncology community remain up-to-date regarding published data and clinical guidelines related to lifestyle optimization in patients living with prostate cancer. Participants need to know how the latest evidence and guidelines affect their day-to-day interactions with patients in practice, and thus be able to narrow competency gaps in prostate cancer care. In the first presentation we discuss the latest evidence on the benefits of plant-predominant nutrition for patients with prostate cancer, including oncologic outcomes and quality of life. In addition, we discuss the importance of the other major pillars of lifestyle medicine in prostate cancer (physical activity, sleep health, avoidance of toxic substances, stress management and social support).
Misinformation about prostate cancer is widespread in online networks and commonly raised during clinical encounters. Failing to address information can result in harms for patients, and challenging discussions about misinformation can lead to discord in the patient-clinician relationship. It's important that radiation oncologists are aware of the most common types of misinformation that are circulating about prostate cancer. This session provides participants with a summary. Radiation oncologists need strategies to help combat misinformation about prostate cancer and to handle patient encounters where misinformation is discussed. In the second presentation we discuss the most common types of misinformation that are circulating about prostate cancer and review strategies to use in clinical encounters with patients where misinformation is discussed.
Topics:
- Evidence-Based Recommendations on Nutrition and Lifestyle in Prostate Cancer
Stacy Loeb, MD, MSc., PhD (Hon)
Neha Vapiwala, MD, FASTRO, FASCO - Moderator - Common Misinformation About Prostate Cancer and What To Do
Stacy Loeb, MD, MSc., PhD (Hon)
Neha Vapiwala, MD, FASTRO, FASCO - Moderator
This activity was originally presented as two live webinars on May 21, 2026 and June 8, 2026. The activity is available from June 11, 2026 through 11:59 am Eastern time on June 10, 2028.
Target Audience
The activity is designed to meet the interests of medical oncologists, radiation oncologists, surgeons, residents and nurses.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Summarize the key epidemiological data linking diet and lifestyle with incidence, progression and quality of life in prostate cancer.
- Describe current guidelines on lifestyle for prostate cancer survivors.
- List common myths that are circulating about prostate cancer in online networks.
- Apply strategies to address misinformation while maintaining the patient-physician relationship.
Moderator:
- Neha Vapiwala, MD, FASTRO, FASCO, is employed by the University of Pennsylvania. Dr. Vapiwala has no relevant financial relationship with ineligible companies to disclose.
Speaker:
- Stacy Loeb, MD, MSc., PhD (Hon), is employed by New York University Langone Health and Manhattan Veterans Affairs. Dr. Loeb receives compensation/payment from Savor Health and grant/research funding from Endo USA, Inc. Dr. Loeb received compensation/payment from Astellas (relationship ended 9/30/2025), Sumitomo (relationship ended 10/3/2025) and Pfizer (relationship ended 10/29/2025).
Planners:
- Malcolm Mattes, MD, is employed at Rutgers Cancer Institute. Dr. Mattes received research/grant funding from Gilead Sciences (relationship ended 8/30/2025). Dr. Mattes has no relevant financial relationship with ineligible companies.
- Parul Barry, MD, is employed by the University of Pittsburgh Medical Center. Dr. Barry has no relevant financial relationship with ineligible companies.
- Michael Haddock, MD, is employed by Mayo Clinic and has no relevant financial relationship with ineligible companies to disclose.
- Manisha Palta, MD, is employed by Duke Cancer Center and Duke University Hospital. Dr. Palta receives grant/research funding from Merck and Varian Medical Systems.
- Salma Jabbour, MD, is employed by Rutgers Cancer Institute. Dr. Jabbour receives grant/research funding from Merck & Co., Inc. and Beigene. Dr. Jabbour receives compensation/payment as a consultant with Radialogica and IMX Medical.
All relevant financial relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Available Credit
- 2.00 AMA PRA Category 1 Credit™
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 2.00 Certificate of AttendanceThis activity was designated for 2.00 AMA PRA Category 1 Credit™.
Price
Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the member rate.
- Nonmember: $99
- Member: $49
- Member-in-Training: $29
- Student/Graduate Student/PGY-1 Member: $29
- Postdoctoral Fellow Member: $29
If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.
Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.
Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.
The activity and its materials will only be available on the ASTRO website until June 10, 2028, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.

Facebook
X
LinkedIn
Forward